Literature DB >> 14985337

The C-terminal domain is the primary determinant of histone H1 binding to chromatin in vivo.

Michael J Hendzel1, Melody A Lever, Ellen Crawford, John P H Th'ng.   

Abstract

We have used a combination of kinetic measurements and targeted mutations to show that the C-terminal domain is required for high-affinity binding of histone H1 to chromatin, and phosphorylations can disrupt binding by affecting the secondary structure of the C terminus. By measuring the fluorescence recovery after photo-bleaching profiles of green fluorescent protein-histone H1 proteins in living cells, we find that the deletion of the N terminus only modestly reduces binding affinity. Deletion of the C terminus, however, almost completely eliminates histone H1.1 binding. Specific mutations of the C-terminal domain identified Thr-152 and Ser-183 as novel regulatory switches that control the binding of histone H1.1 in vivo. It is remarkable that the single amino acid substitution of Thr-152 with glutamic acid was almost as effective as the truncation of the C terminus to amino acid 151 in destabilizing histone H1.1 binding in vivo. We found that modifications to the C terminus can affect histone H1 binding dramatically but have little or no influence on the charge distribution or the overall net charge of this domain. A comparison of individual point mutations and deletion mutants, when reviewed collectively, cannot be reconciled with simple charge-dependent mechanisms of C-terminal domain function of linker histones.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14985337     DOI: 10.1074/jbc.M400070200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  103 in total

1.  P-TEFb kinase complex phosphorylates histone H1 to regulate expression of cellular and HIV-1 genes.

Authors:  Siobhan K O'Brien; Hong Cao; Robin Nathans; Akbar Ali; Tariq M Rana
Journal:  J Biol Chem       Date:  2010-06-15       Impact factor: 5.157

2.  Dynamics of the higher-order structure of chromatin.

Authors:  Ping Chen; Guohong Li
Journal:  Protein Cell       Date:  2010-11       Impact factor: 14.870

Review 3.  The H1 linker histones: multifunctional proteins beyond the nucleosomal core particle.

Authors:  Sonja P Hergeth; Robert Schneider
Journal:  EMBO Rep       Date:  2015-10-15       Impact factor: 8.807

Review 4.  Role of H1 linker histones in mammalian development and stem cell differentiation.

Authors:  Chenyi Pan; Yuhong Fan
Journal:  Biochim Biophys Acta       Date:  2015-12-13

5.  The preferential binding of histone H1 to DNA scaffold-associated regions is determined by its C-terminal domain.

Authors:  Alicia Roque; Mary Orrego; Imma Ponte; Pedro Suau
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

6.  Differential in vivo binding dynamics of somatic and oocyte-specific linker histones in oocytes and during ES cell nuclear transfer.

Authors:  Matthias Becker; Antje Becker; Faiçal Miyara; Zhiming Han; Maki Kihara; David T Brown; Gordon L Hager; Keith Latham; Eli Y Adashi; Tom Misteli
Journal:  Mol Biol Cell       Date:  2005-06-08       Impact factor: 4.138

Review 7.  Role of linker histone in chromatin structure and function: H1 stoichiometry and nucleosome repeat length.

Authors:  Christopher L Woodcock; Arthur I Skoultchi; Yuhong Fan
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

Review 8.  Chromatin architectural proteins.

Authors:  Steven J McBryant; Valerie H Adams; Jeffrey C Hansen
Journal:  Chromosome Res       Date:  2006       Impact factor: 5.239

9.  Chromatin condensing functions of the linker histone C-terminal domain are mediated by specific amino acid composition and intrinsic protein disorder.

Authors:  Xu Lu; Barbara Hamkalo; Missag H Parseghian; Jeffrey C Hansen
Journal:  Biochemistry       Date:  2009-01-13       Impact factor: 3.162

10.  During lytic infections, herpes simplex virus type 1 DNA is in complexes with the properties of unstable nucleosomes.

Authors:  Jonathan J Lacasse; Luis M Schang
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.